Sezer S - Search Results

1

Risk factors for kidney impairment and differential impact of liver transplantation on renal function.

Sezer S, Karakan S, Erişmiş B, Çolak T, Haberal M. Sezer S, et al. Transplant Proc. 2011 Mar;43(2):609-11. doi: 10.1016/j.transproceed.2011.01.045. Transplant Proc. 2011. PMID: 21440776

2

Comparison of panel reactive antibody levels with clinical and laboratory parameters in end-stage renal disease patients.

Sezer S, Ozdemir FN, Turan M, Güz G, Haberal A, Kaya S, Bilgin N. Sezer S, et al. Transplant Proc. 1998 May;30(3):844-5. doi: 10.1016/s0041-1345(98)00072-4. Transplant Proc. 1998. PMID: 9595122 No abstract available.

3

Tuberculosis remains an important factor in the morbidity and mortality of hemodialysis patients.

Ozdemir FN, Güz G, Kayataş M, Sezer S, Arslan H, Turan M. Ozdemir FN, et al. Among authors: sezer s. Transplant Proc. 1998 May;30(3):846-7. doi: 10.1016/s0041-1345(98)00073-6. Transplant Proc. 1998. PMID: 9595123 No abstract available.

4

Prevalence of serological markers of autoimmunity in hemodialysis patients with hepatitis C virus.

Ozdemir FN, Turan M, Sezer S, Kayataş M, Haberal A, Güz G, Erten Y, Hizel N, Boyacioğlu S, Gülmüş S, Bilgin N. Ozdemir FN, et al. Among authors: sezer s. Transplant Proc. 1998 May;30(3):848-9. doi: 10.1016/s0041-1345(98)00074-8. Transplant Proc. 1998. PMID: 9595124 No abstract available.

5

Zinc deficiency: prevalence and causes in hemodialysis patients and effect on cellular immune response.

Erten Y, Kayataş M, Sezer S, Ozdemir FN, Ozyiğit PF, Turan M, Haberal A, Güz G, Kaya S, Bilgin N. Erten Y, et al. Among authors: sezer s. Transplant Proc. 1998 May;30(3):850-1. doi: 10.1016/s0041-1345(98)00075-x. Transplant Proc. 1998. PMID: 9595125 No abstract available.

6

Immunologic profile of end-stage renal failure patients.

Sezer S, Ozdemir N, Güz G, Turan M, Arslan S, Haberal M. Sezer S, et al. Transplant Proc. 1999 Dec;31(8):3359-60. doi: 10.1016/s0041-1345(99)00825-8. Transplant Proc. 1999. PMID: 10616506 No abstract available.

7

Tumor markers in hemodialysis patients.

Arican A, Ozdemir N, Sezer S, Erten Y, Güz G, Turan M, Inanoglu I, Haberal M. Arican A, et al. Among authors: sezer s. Transplant Proc. 1999 Dec;31(8):3367-8. doi: 10.1016/s0041-1345(99)00846-5. Transplant Proc. 1999. PMID: 10616509 No abstract available.

8

Anticardiolipin antibodies in hemodialysis patients.

Ozdemir N, Güz G, Sezer S, Haberal A, Ayaz H, Haberal M. Ozdemir N, et al. Among authors: sezer s. Transplant Proc. 1999 Dec;31(8):3388-9. doi: 10.1016/s0041-1345(99)00834-9. Transplant Proc. 1999. PMID: 10616518 No abstract available.

9

Factors influencing response to hepatitis B virus vaccination in hemodialysis patients.

Sezer S, Ozdemir FN, Güz G, Arat Z, Colak T, Sengul S, Turan M, Haberal A, Erdal R. Sezer S, et al. Transplant Proc. 2000 May;32(3):607-8. doi: 10.1016/s0041-1345(00)00914-3. Transplant Proc. 2000. PMID: 10812136 No abstract available.

10

Ambulatory blood pressure monitoring in potential renal transplant donors.

Ozdemir FN, Güz G, Sezer S, Arat Z, Haberal M. Ozdemir FN, et al. Among authors: sezer s. Nephrol Dial Transplant. 2000 Jul;15(7):1038-40. doi: 10.1093/ndt/15.7.1038. Nephrol Dial Transplant. 2000. PMID: 10862644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters